Efficacy and safety of enzalutamide, abiraterone and cabazitaxel in post-docetaxel treatment of castration-resistant prostate cancer: meta-analysis data

P. V. Mazin; N. K. Mazina

For citations:

Mazin P.V., Mazina N.K. Efficacy and safety of enzalutamide, abiraterone and cabazitaxel in post-docetaxel treatment of castration-resistant prostate cancer: meta-analysis data. Cancer Urology. 2017;13(4):91-100. (In Russ.) https://doi.org/10.17650/1726-9776-2017-13-4-91-100

Views PDF (Rus): 1289

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy